Table 2.
Base-case analysis
| Screening strategy | Cost, R$ | Incr. cost, R$ | QALY | Incr. QALY | ICER (R$/QALY gained) |
|---|---|---|---|---|---|
| Opportunistic ophthalmology referral-based | 841 | 0 | 10.136 | 0 | 0 |
| Systematic teleophthalmology-based | 1744 | 903 | 10.178 | 0.042 | 21445 |
| Systematic ophthalmology referral-based | 1748 | 4 | 10.165 | − 0.012 | Dominated |
C/E cost-effectiveness ratio, ICER incremental cost-effectiveness ratio, Incr. incremental, (Incr. cost/Incr. QALY), QALY quality-adjusted life-year, R$ Reais